The senior management team of Shaanxi Tianrdi Renhe Pharmaceutical Co., Ltd. made a grand appearance at the 89th PharmChina of 2024(WUHAN) to jointly draw a new blueprint for the pharmaceutical industry
update time：2024-11-20 Visitors：1
From November 20th to 22nd, 2024, the 89th PHARMCHINA of 2024(WUHAN) referred to as "Wuhan Pharmaceutical Fair") was grandly opened at the Wuhan International Expo Center. As one of the most influential industry events in China's pharmaceutical and healthcare sector, this exhibition attracted thousands of well-known pharmaceutical companies, industry experts, and enterprises from the entire industrial chain.
The senior management team of Shaanxi Tiandi Renhe Pharmaceutical Co., LTD. (hereinafter referred to as "Tiandi Renhe Pharmaceutical"), led by the Group's General Manager, Executive Vice Genral Manager, and Marketing Director, participated in the exhibition, showcasing multiple core products and innovative achievements, demonstrating the company's strong development momentum, and exploring new cooperation opportunities with industry partners.
During the period of the exhibition, a delegation of the company's senior management visited the booths of several key cooperative enterprises and held in-depth talks with representatives of many leading companies. The Executive Vice General Mangaer Mr. Mei Shengliang stated, "The Wuhan Pharmaceutical Fair is a barometer of the industry. We hope to further strengthen collaborative innovation with partners in the industrial chain, accelerate the integration of market resources, and promote the penetration of our core products across the country through this platform."
Tiandi Renhe Pharmaceutical booth was themed "Empowering Health with Technology, Guarding Life with Craftsmanship", highlighting 6 exclusive products. Among them, the star products such as Guyuling capsule, Levornidazole Disodium phosphate drew and other products with standardized production technology and clinical efficacy data, attracted many distributors and representatives of medical institutions to stop by for inquiries. During the exhibition, the company also successfully signed multiple strategic cooperation agreements.
The trip to the Wuhan Pharmaceutical Fair not only provided a window for Tiandi Renhe Pharmaceutical to showcase its strength, but also laid a solid foundation for the company to connect industry resources and gain insights into market trends. Taking this exhibition as a starting point, the company will continue to deepen its "innovation and cooperation" dual-wheel drive strategy, accelerate the national market layout, and inject new impetus into the high-quality development of China's pharmaceutical and healthcare industry.
